Answers are grounded in this paper and cite their sources.
Our results suggested that the use of inhibitors that directly target the translation initiation complex eIF4F could represent a potential novel approach for multiple myeloma therapy.
No takes yet. Share an insight, caveat, or question.
Descamps et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: